GEFISTERIS 250 (Oncology): Uses & Mechanism of Action, Dosage, Side Effects, Precautions and Warning.

GEFISTERIS 250 is an oral medication used in the field of oncology, specifically designed to treat certain types of cancer. This section provides detailed information about its usage, mechanism of action, side effects, and necessary precautions.

Uses

Uses of GEFISTERIS 250 is primarily utilized for treating non-small cell lung cancer (NSCLC) and pancreatic cancer. It is often prescribed for patients who have specific genetic mutations or have not responded to other cancer treatments.

Mechanism of Action

GEFISTERIS 250 belongs to a class of drugs known as tyrosine kinase inhibitors. It works by blocking the action of an enzyme known as tyrosine kinase. This inhibition disrupts the growth and spread of cancer cells, which rely on this enzyme to proliferate and survive.

Dosage and Administration

The standard dose of GEFISTERIS 250 is one tablet taken orally, usually once daily. The exact dosage and treatment duration depend on the patient's medical condition, response to treatment, and other factors. It is crucial to follow the healthcare provider’s instructions precisely.

Side Effects

Common side effects of GEFISTERIS 250 include:

• Diarrhea

• Skin rash

• Nausea and vomiting

• Fatigue

• Loss of appetite

• Liver function changes

Patients may experience more severe side effects, such as severe pulmonary toxicity, liver toxicity, or gastrointestinal perforation. Immediate medical attention is required if serious side effects are noticed.

Precautions and Warnings

Before starting the precautions of GEFISTERIS 250, patients should inform their healthcare provider about their medical history, especially if they have liver or kidney problems, lung disease, or a history of severe gastrointestinal issues.

Regular monitoring of liver function, kidney function, and lung status is recommended during treatment with GEFISTERIS 250 to detect and manage potential adverse effects promptly.

Conclusion

GEFISTERIS 250 is a vital medication in the treatment of certain types of cancer, offering hope to patients with specific genetic markers or those who have not benefited from other treatments. Adhering to the prescribed dosage, monitoring for side effects, and maintaining open communication with healthcare providers are key to achieving the best outcomes with this medication. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.For further information: EMAIL:  info@sterispharma.com  / contact@sterispharma.com   CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 BUY NOW